Ofer Mandelboim

Person

Shoham, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies specific to human t-cell immunoglobulin and ITIM domain...
- Patent number 12,121,579
- Issue date Oct 22, 2024
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer Mandelboim
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies specific to human NECTIN4
- Patent number 12,077,583
- Issue date Sep 3, 2024
- NECTIN THERAPEUTICS LTD.
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific to human T-cell immunoglobulin and ITIM domain...
- Patent number 10,946,095
- Issue date Mar 16, 2021
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Attenuated or inactivated pathogenic Escherichia coli for treating...
- Patent number 10,918,677
- Issue date Feb 16, 2021
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific to human poliovirus receptor (PVR)
- Patent number 10,906,987
- Issue date Feb 2, 2021
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer Mandelboim
- G01 - MEASURING TESTING
Information Patent Grant
Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same
- Patent number 10,716,864
- Issue date Jul 21, 2020
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer Mandelboim
- G01 - MEASURING TESTING
Information Patent Grant
Method of treating type 1 diabetes by administering NKp46 polypeptide
- Patent number 8,980,244
- Issue date Mar 17, 2015
- Ben-Gurion University of the Negev Research and Development Authority
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating diabetes by administering an anti-NKp46 antibody
- Patent number 8,420,092
- Issue date Apr 16, 2013
- Ben-Gurion University of the Negev Research and Development Authority
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fragments of NKp44 and NKp46 for targeting viral-infected and tumor...
- Patent number 7,825,085
- Issue date Nov 2, 2010
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES AGAINST CD112R AND USES THEREOF
- Publication number 20240270840
- Publication date Aug 15, 2024
- NECTIN THERAPEUTICS LTD.
- Pinchas TSUKERMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)
- Publication number 20240018257
- Publication date Jan 18, 2024
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS...
- Publication number 20230183342
- Publication date Jun 15, 2023
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Stipan JONJIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN NECTIN-2
- Publication number 20220112283
- Publication date Apr 14, 2022
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN...
- Publication number 20210220472
- Publication date Jul 22, 2021
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN NECTIN4
- Publication number 20210130459
- Publication date May 6, 2021
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)
- Publication number 20210115150
- Publication date Apr 22, 2021
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)
- Publication number 20200040092
- Publication date Feb 6, 2020
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ATTENUATED OR INACTIVATED PATHOGENIC ESCHERICHIA COLI FOR TREATING...
- Publication number 20180333439
- Publication date Nov 22, 2018
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-NKP46 ANTIBODIES, TOXIN CONJUGATES, AND THERAPEUTIC USE OF SAME
- Publication number 20180207290
- Publication date Jul 26, 2018
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC TO HUMAN T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN...
- Publication number 20180185480
- Publication date Jul 5, 2018
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Ofer MANDELBOIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER
- Publication number 20180028601
- Publication date Feb 1, 2018
- Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Gilad Benjamin BACHRACH
- G01 - MEASURING TESTING
Information Patent Application
METHOD FOR TREATING TYPE 1 DIABETES
- Publication number 20130280209
- Publication date Oct 24, 2013
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF NKP46 FOR PREVENTING DIABETES
- Publication number 20120076753
- Publication date Mar 29, 2012
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NK Cell Receptor Conjugates for Treating Malignancies
- Publication number 20100047169
- Publication date Feb 25, 2010
- NATSPEARS, LTD.
- Ofer MANDELBOIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Peptides Derived from Natural Cytotoxicity Receptors and Methods of...
- Publication number 20070280938
- Publication date Dec 6, 2007
- YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fragments of nkp44 for targeting viral-infected and tumor cells
- Publication number 20070203054
- Publication date Aug 30, 2007
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nk cell receptor conjugates for treating malignancies
- Publication number 20060165592
- Publication date Jul 27, 2006
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nk cells activiating receptors and their therapeutic and diagnostic...
- Publication number 20040072256
- Publication date Apr 15, 2004
- Ofer Mandelboim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ofer Mandelboim

Person

Patents Grantslast 30 patents

Antibodies specific to human t-cell immunoglobulin and ITIM domain...

Antibodies specific to human NECTIN4

Antibodies specific to human T-cell immunoglobulin and ITIM domain...

Attenuated or inactivated pathogenic Escherichia coli for treating...

Antibodies specific to human poliovirus receptor (PVR)

Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same

Method of treating type 1 diabetes by administering NKp46 polypeptide

Method of treating diabetes by administering an anti-NKp46 antibody

Fragments of NKp44 and NKp46 for targeting viral-infected and tumor...

Patents Applicationslast 30 patents

ANTIBODIES AGAINST CD112R AND USES THEREOF

ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)

ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF CANCERS...

ANTIBODIES SPECIFIC TO HUMAN NECTIN-2

ANTIBODIES SPECIFIC TO HUMAN T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN...

ANTIBODIES SPECIFIC TO HUMAN NECTIN4

ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)

ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)

ATTENUATED OR INACTIVATED PATHOGENIC ESCHERICHIA COLI FOR TREATING...

ANTI-NKP46 ANTIBODIES, TOXIN CONJUGATES, AND THERAPEUTIC USE OF SAME

ANTIBODIES SPECIFIC TO HUMAN T-CELL IMMUNOGLOBULIN AND ITIM DOMAIN...

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHOD FOR TREATING TYPE 1 DIABETES

USE OF NKP46 FOR PREVENTING DIABETES

NK Cell Receptor Conjugates for Treating Malignancies

Peptides Derived from Natural Cytotoxicity Receptors and Methods of...

Fragments of nkp44 for targeting viral-infected and tumor cells

Nk cell receptor conjugates for treating malignancies

Nk cells activiating receptors and their therapeutic and diagnostic...